In this episode of the “CURE® Talks Cancer” podcast, we spoke with Dr. Naveen Pemmaraju, associate professor of Leukemia at The University of Texas MD Anderson Cancer Center, who recently conducted research on disease awareness in patients with myeloproliferative neoplasms (MPNs).
Many patients with MPNs reported going to the internet to seek out information about their disease; however, many still did not know about some of the common markers of their disease. While the internet can be a great source of information, there is plenty of misinformation available, too, so it is always important that patients take what they find online and talk to their providers about it.
Read more: https://www.curetoday.com/view/how-to-find-reliable-cancer-information-online
Social Media and Rare Cancers: Stay Informed, But Tread With Caution
Social media and the internet as a whole can offer a wealth of information and connections for patients with cancer, especially those with rarer diseases. However, patients should always bring the online advice to their health care team, says Dr. Naveen Pemmaraju.
In this episode of the “CURE® Talks Cancer” podcast, we spoke with Dr. Naveen Pemmaraju, associate professor of Leukemia at The University of Texas MD Anderson Cancer Center, who recently conducted research on disease awareness in patients with myeloproliferative neoplasms (MPNs).
Many patients with MPNs reported going to the internet to seek out information about their disease; however, many still did not know about some of the common markers of their disease. While the internet can be a great source of information, there is plenty of misinformation available, too, so it is always important that patients take what they find online and talk to their providers about it.
Read more: https://www.curetoday.com/view/how-to-find-reliable-cancer-information-online
TIL Therapy Promising in Uveal Melanoma, Tool Predicts Responders
April 17th 2024A type of therapy that involves “liberating” T cells from a suppressive tumor environment showed promise in the treatment of patients with uveal melanoma.
Read More
Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine
March 11th 2024Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Listen
Lower Childbirth Rates Shown in Women With MPNs
April 3rd 2024Childbirth rates have been reduced by 22% in women with MPNs, compared with women without MPNs, researchers found.
Read More
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
March 4th 2024In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Listen
Caregivers Are The ‘Mouthpiece’ For Patients in Clinical Trials
March 21st 2024One expert explains how caregivers are a vital part of the care team during a clinical trial.
Read More
The Scanxiety Wait During Cancer is the Hardest Part
March 20th 2024The waiting in between scans heightens my scanxiety, even though I've had no evidence of disease for 2 1/2 years.
Read More
TIL Therapy Promising in Uveal Melanoma, Tool Predicts Responders
April 17th 2024A type of therapy that involves “liberating” T cells from a suppressive tumor environment showed promise in the treatment of patients with uveal melanoma.
Read More
Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine
March 11th 2024Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Listen
Lower Childbirth Rates Shown in Women With MPNs
April 3rd 2024Childbirth rates have been reduced by 22% in women with MPNs, compared with women without MPNs, researchers found.
Read More
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
March 4th 2024In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Listen
Caregivers Are The ‘Mouthpiece’ For Patients in Clinical Trials
March 21st 2024One expert explains how caregivers are a vital part of the care team during a clinical trial.
Read More
The Scanxiety Wait During Cancer is the Hardest Part
March 20th 2024The waiting in between scans heightens my scanxiety, even though I've had no evidence of disease for 2 1/2 years.
Read More